Other Non-Current Liabilities
Merck & Co. Other Non-Current Liabilities decreased by 0.6% to $7.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.8%, from $6.66B to $7.64B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -9.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.87B | $9.47B | $9.43B | $9.74B | $8.95B | $8.66B | $8.32B | $8.24B | $7.27B | $7.34B | $8.79B | $8.26B | $7.33B | $7.54B | $6.47B | $6.66B | $7.03B | $7.66B | $7.69B | $7.64B |
| QoQ Change | — | -4.1% | -0.4% | +3.3% | -8.1% | -3.3% | -3.9% | -0.9% | -11.9% | +1.1% | +19.7% | -6.0% | -11.3% | +2.9% | -14.3% | +2.9% | +5.6% | +9.0% | +0.4% | -0.6% |
| YoY Change | — | — | — | — | -9.3% | -8.5% | -11.8% | -15.4% | -18.8% | -15.2% | +5.6% | +0.2% | +0.9% | +2.7% | -26.5% | -19.5% | -4.1% | +1.6% | +18.9% | +14.8% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s other non-current liabilities?
- Merck & Co. (MRK) reported other non-current liabilities of $7.64B in Q1 2026.
- How has Merck & Co.'s other non-current liabilities changed year-over-year?
- Merck & Co.'s other non-current liabilities increased by 14.8% year-over-year, from $6.66B to $7.64B.
- What is the long-term trend for Merck & Co.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Merck & Co.'s other non-current liabilities has grown at a -9.0% compound annual growth rate (CAGR), from $12.31B to $7.69B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.